Feature|Videos|November 19, 2025
Setting the Stage: The Boardroom Hot Seat
Author(s)David Edelman, Thrivable
This episode acts as a peek inside the modern pharma boardroom, where leaders are expected to defend billion-dollar brands with data that’s too slow, too vague, and too outdated to survive today’s market velocity.
Advertisement
This episode spotlights the escalating pressure inside the pharma boardroom. Markets are shifting overnight, competitors are moving at warp speed, and leaders are expected to explain performance with data that’s six weeks old and only tells half the story. Teams feel unprepared while the stakes have never been higher; from sudden GLP-1 coverage changes to compounding pharmacy disruptions, massive market swings can happen in a weekend. This is the new hot seat, and hesitation or guesswork can cost billions.
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Trending on PharmExec
1
The Importance of Suppressor Cells in Tumor Progression
2
Winners & Losers: What the First FDA Commissioner’s National Priority Vouchers Tell Us About Early Movers vs. Late Movers
3
How the FDA Commissioner’s National Priority Vouchers Reshape Manufacturing, Pricing & Global Strategy
4
Avadel Pharmaceuticals Agrees to Alkermes’ Revised Acquisition Offer
5
